✦ LIBER ✦

A role for the androgen receptor in the endometrial antiproliferative effects of progesterone antagonists

✍ Scribed by Robert M Brenner; Ov D Slayden; Nihar R Nayak; David T Baird; Hilary O.D Critchley

Book ID: 117213654
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 449 KB
Volume: 68
Category: Article
ISSN: 0039-128X
DOI: 10.1016/s0039-128x(03)00120-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiproliferative effects of progesteron

Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium

✍ Kristof Chwalisz; Robert M Brenner; Ulrike U Fuhrmann; Holger Hess-Stumpp; Walte 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 553 KB

A bioassay for the evaluation of antipro

A bioassay for the evaluation of antiproliferative potencies of progesterone antagonists

✍ Michna, H.; Nishino, Y.; Schneider, M.R.; Louton, T.; El Etreby, M.F. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 655 KB

The antitumor mechanism of progesterone

The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell death

✍ H. Michna; M.R. Schneider; Y. Nishino; M.F. El Etreby 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 890 KB

Antiproliferative actions of the synthet

Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors

✍ Elisa J. Cops; Tina Bianco-Miotto; Nicole L. Moore; Christine L. Clarke; Stephen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 686 KB

Progesterone antagonists and progesteron

Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer

✍ Jan G.M. Klijn; Buddy Setyono-Han; John A. Foekens 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Progesterone antagonists and progesteron

Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer

✍ Jan G.M. Klijn; Buddy Setyono-Han; John A. Foekens 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Progesterone antagonists (PAs) (antiprogestins) or progesterone receptor modulators (PRMs) form an interesting category of new hormonal agents in the treatment of breast cancer. In vitro, antiproliferative effects of different PAs are mainly observed in estrogen-stimulated growth of PR-positive tumo